News Releases Keyword Search Year None20232022202120202019201820172016 Dec-06-2016 Oncternal’s Pipeline Candidates Featured in Presentations at American Society of Hematology Meeting Aug-30-2016 Oncternal Therapeutics Initiates Patient Dosing in Phase 1 Clinical Trial of TK216 in Ewing Sarcoma Jul-13-2016 TK216 Receives Orphan Drug Designation for the Treatment of Ewing Sarcoma, a Rare Pediatric Cancer Jun-20-2016 Oncternal Receives Fast Track Designation for TK216 in Relapsed or Refractory Ewing Sarcoma Jun-01-2016 Oncternal Merges with Tokalas to Form Clinical-Stage Biotech Company w/ Promising Oncology Pipeline Apr-12-2016 Oncternal Awarded Exclusive Worldwide License to ROR1 Antibody and Related Programs from UCSD Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14
